Owner Novartis AG. Xenon Pharmaceuticals Inc.

Inventors Winther, Michael D.; Billich, Andreas; Winzenburg, Gesine; Fritze, Andreas; Goldberg, Yigal Paul; Rapp, Karin

Agent Davies Collison Cave

Pub. Number AU-A-2009219809

PCT Pub. Number WO2009/106991

Priority 12/036,685 25.02.08 US

Filing date 19 February 2009

Wipo publication date 3 September 2009

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 47/08 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing oxygen

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/08 (2006.01) Drugs for dermatological disorders

A61P 17/10 (2006.01) Drugs for dermatological disorders